Phase 0/I/II Cancer Prevention Clinical Trials Program Clinical Trials

Titlesort descending Intervention NCT ID Sponsor Status
Erlotinib Hydrochloride in Preventing Liver Cancer in Patients With Cirrhosis of the Liver Erlotinib Hydrochloride, Laboratory Biomarker Analysis, Quality-of-Life Assessment NCT02273362 National Cancer Institute (NCI) Recruiting
Erlotinib Hydrochloride in Reducing Duodenal Polyp Burden in Patients With Familial Adenomatous... Erlotinib Hydrochloride, Laboratory Biomarker Analysis NCT02961374 National Cancer Institute (NCI) Recruiting
Exemestane in Treating Patients With Complex Atypical Hyperplasia of the Endometrium/Endometrial... Exemestane, Laboratory Biomarker Analysis, Pharmacological Study, Questionnaire Administration NCT03300557 National Cancer Institute (NCI) Recruiting
Iloprost in Preventing Lung Cancer in Former Smokers Iloprost, Laboratory Biomarker Analysis, Placebo, Quality-of-Life Assessment, Questionnaire Administration NCT02237183 National Cancer Institute (NCI) Recruiting
Immunogenicity of Nonavalent HPV Vaccine Administered Prior to Living Donor Renal Transplantation... Laboratory Biomarker Analysis, Questionnaire Administration, Recombinant Human Papillomavirus Nonavalent Vaccine NCT03036930 National Cancer Institute (NCI) Recruiting
Intermittent or Continuous Acetylsalicylic Acid and Gene Expression in the Nasal Tissue of Current... Aspirin, Laboratory Biomarker Analysis, Placebo NCT02123849 National Cancer Institute (NCI) Completed
Linaclotide Acetate in Preventing Colorectal Cancer in Healthy Volunteers linaclotide acetate, placebo, pharmacological study, laboratory biomarker analysis NCT01950403 Mayo Clinic Completed
Metformin Hydrochloride in Preventing Oral Cancer in Patients With an Oral Premalignant Lesion Laboratory Biomarker Analysis, Metformin Hydrochloride NCT02581137 National Cancer Institute (NCI) Active, not recruiting
Naproxen in Preventing DNA Mismatch Repair Deficient Colorectal Cancer in Patients With Lynch... Laboratory Biomarker Analysis, Naproxen, Placebo NCT02052908 National Cancer Institute (NCI) Active, not recruiting
Natural History of Lung Nodules Seen on CT Scans From Participants at High-Risk of Developing Lung... medical chart review, computed tomography, computer-aided detection/diagnosis NCT01540552 M.D. Anderson Cancer Center Completed